Literature DB >> 6170721

Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.

L H Glimcher, D L Longo, I Green, R H Schwartz.   

Abstract

A system has been described that produces a murine syngeneic mixed lymphocyte response (MLR) comparable in magnitude to an allogeneic MLR. The responder cells in these cultures exhibit the classic immunologic characteristics of both memory and specificity. Studies using radiation-induced bone marrow chimeras of F(1) {arrow} parent type indicated that, similar to many other T cell-mediated immune responses, the response of the T lymphocytes in the syngeneic MLR was major histocompatibility complex-restricted and was determined by the environment in which the T cells matured. Using responder T cells from F(1) {arrow} parent chimeras and stimulator cells from H-2 recombinant strains, it was possible to map the genes involved in the stimulation to the K and/or I regions. In addition, blocking studies with monoclonal anti-Ia antibodies suggested that in the B10.A strain the critical molecules were products of both the I-A(k) and I-E(k) subregions. The issue of whether the syngeneic MLR is directed solely at self I-region antigens or whether the response represents proliferation to an unknown antigen in association with self I-region determinants was also addressed. Secondary syngeneic MLR were successfully performed in normal mouse serum and with stimulator cells prepared in the absence of bovine serum albumin to rule out the possibility that xenogeneic serum antigens were involved in the stimulation. The possibility that the syngeneic MLR might represent a secondary response to environmental antigens was eliminated by using germ- free mice as a source of stimulator cells and by demonstrating that spleen cells from unimmunized, fully allogeneic chimeras (B10.A {arrow} B10) could generate a normal syngeneic MLR even though such chimeras could not be primed to respond to any foreign antigens unless supplemented in vivo with a source of antigen-presenting cells syngeneic to the B10 host. The possibility that the syngeneic MLR was a primary response to a foreign antigen was considered unlikely because by using our culture conditions we could not obtain a primary antigen response or a secondary antigen response after in vitro priming to a variety of potent foreign antigens. Finally, the possibility that the syngeneic MLR represents a response to a variety of minor histocompatibility self antigens in association with self Ia molecules was eliminated by showing that the secondary responses to H-2 compatible, non-H-2 different strain (A/J vs. B10.A and C3H, or BALB/c vs. B10.D2 and DBA/2) were comparable to the secondary responses to syngeneic stimulators. Thus, we conclude that the target antigens in the syngeneic MLR are solely determinants on self Ia molecules, although the functionally equivalent possibility of a single, nonpolymorphic, minor self antigen seen in association with self Ia molecules cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170721      PMCID: PMC2186517          DOI: 10.1084/jem.154.5.1652

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus.

Authors:  R M Zinkernagel; G N Callahan; J Klein; G Dennert
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

3.  Syngeneic mixed lymphocyte reaction between thymocytes and peripheral lymphoid cells in mice: strain specificity and nature of the target cell.

Authors:  H Von Boehmer; P B Adams
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

4.  Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes.

Authors:  N M Ponzio; J H Finke; J R Battisto
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

5.  In a fully H-2 incompatible chimera, T cells of donor origin can respond to minor histocompatibility antigens in association with either donor or host H-2 type.

Authors:  P Matzinger; G Mirkwood
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

6.  Adaptive differentiation of murine lymphocytes. I. Both T and B lymphocytes differentiating in F1 transplanted to parental chimeras manifest preferential cooperative activity for partner lymphocytes derived from the same parental type corresponding to the chimeric host.

Authors:  D H Katz; B J Skidmore; L R Katz; C A Bogowitz
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

7.  Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain.

Authors:  J Sprent; H V Boehmer; M Nabholz
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

8.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.

Authors:  A Singer; K S Hathcock; R J Hodes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  38 in total

1.  Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.

Authors:  Patricia K A Mongini; Jill M Kramer; Tomo-O Ishikawa; Harvey Herschman; Donna Esposito
Journal:  Clin Immunol       Date:  2014-03-29       Impact factor: 3.969

2.  Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.

Authors:  J P Zou; J Shimizu; K Ikegame; H Takiuchi; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Suppression of lymphoproliferation by hapten-specific suppressor T lymphocytes from mice exposed to ultraviolet radiation.

Authors:  S E Ullrich
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

4.  Transplantation tolerance correlates with high levels of T- and B-lymphocyte activity.

Authors:  A Bandeira; A Coutinho; C Carnaud; F Jacquemart; L Forni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 5.  Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells.

Authors:  B W Needleman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  Bone marrow-derived thymic antigen-presenting cells determine self-recognition of Ia-restricted T lymphocytes.

Authors:  D L Longo; A M Kruisbeek; M L Davis; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

7.  Fetal calf serum stimulates 'autoreactive' T-cell hybridomas.

Authors:  A M Pullen; A J Munro
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

8.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle.

Authors:  M N Hart; S K Tassell; K L Sadewasser; R L Schelper; S A Moore
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

Review 10.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.